Related Experiment Video
Updated: Jul 27, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Friedreich cardiomyopathy is a desminopathy
Arnulf H Koeppen1,2, Rahman F Rafique1, Joseph E Mazurkiewicz3
1Research Service, Veterans Affairs Medical Center, Albany, NY, USA.
Insights
Friedreich ataxia (FA) cardiomyopathy involves heart muscle changes due to frataxin deficiency. This leads to abnormal accumulation of desmin and αB-crystallin, causing heart muscle damage.
Area of Science:
- Cardiology
- Genetics
- Proteomics
Background:
- Heart disease is a major cause of death in Friedreich ataxia (FA), an autosomal recessive disorder.
- FA results from a mutation causing a lack of the mitochondrial protein frataxin.
- FA affects multiple organs, including the heart, brain, and spinal cord.
Purpose of the Study:
- To investigate the proteomic changes in the heart of FA patients.
- To understand the molecular mechanisms underlying FA cardiomyopathy.
- To determine if FA cardiomyopathy is a desminopathy.
Main Methods:
- Proteomic analysis using antibody microarray.
- Western blots to detect protein expression.
- Immunohistochemistry and confocal microscopy to visualize protein localization.
- Analysis of heart tissue from FA patients and normal controls.
Main Results:
- Upregulation of desmin and αB-crystallin in FA hearts.
- Abnormal aggregation and mislocalization of desmin and αB-crystallin in FA cardiomyocytes.
- Presence of a truncated desmin isoprotein in FA cardiomyopathy.
- Destruction of the cardiomyocyte contractile apparatus and mitochondrial clustering.
Conclusions:
- FA cardiomyopathy is characterized by the accumulation of desmin and αB-crystallin.
- These protein alterations lead to significant cardiac pathology.
- FA cardiomyopathy can be classified as a desminopathy, similar to desmin myopathy in skeletal muscle.
Abstract:
Heart disease is an integral part of Friedreich ataxia (FA) and the most common cause of death in this autosomal recessive disease. The result of the mutation is lack of frataxin, a small mitochondrial protein. The clinical and pathological phenotypes of FA are complex, involving brain, spinal cord, dorsal root ganglia, sensory nerves, heart, and endocrine pancreas. The hypothesis is that frataxin deficiency causes downstream changes in the proteome of the affected tissues, including the heart. A proteomic analysis of heart proteins in FA cardiomyopathy by antibody microarray, Western blots, immunohistochemistry, and double-label laser scanning confocal immunofluorescence microscopy revealed upregulation of desmin and its chaperone protein, αB-crystallin. In normal hearts, these two proteins are co-localized at intercalated discs and Z discs. In FA, desmin and αB-crystallin aggregate, causing chaotic modification of intercalated discs, clustering of mitochondria, and destruction of the contractile apparatus of cardiomyocytes. Western blots of tissue lysates in FA cardiomyopathy reveal a truncated desmin isoprotein that migrates at a lower molecular weight range than wild type desmin. While desmin and αB-crystallin are not mutated in FA, the accumulation of these proteins in FA hearts allows the conclusion that FA cardiomyopathy is a desminopathy akin to desmin myopathy of skeletal muscle.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Desmosomes
Rheumatic Heart Disease I: Introduction

